Insurance company key to Franciscan-American Health partnership
Hospital system’s health insurance unit has IT infrastructure that will allow physicians to participate in Medicare’s shared savings program.
Health Care & Life Sciences
Articles
Westfield health IT firm sold for $473 million
MaxIT’s 1,300 employees, who provide information technology services to hospitals and physician practices, will join Virginia-based Science Applications International Corp.
Daniels looks to successors on health exchange
Gov. Mitch Daniels says he plans to ask his potential successors whether the state should set up a health care exchange.
IU Health makes prestigious Honor Roll list
For the first time, Indiana University Health has been named to U.S. News & World Report's "Best Hospitals Honor Roll," a distinction that goes to the top medical centers in the country.
Reform may hit hospitals harder
The immediate reaction on Wall Street to last month’s U.S. Supreme Court ruling upholding President Obama’s health care law was to buy hospital stocks and dump health insurance stocks. But at least one analyst expects the long-term outcome to be the exact opposite.
Lilly gets boost in Alzheimer’s race
Eli Lilly and Co. got a boost of confidence last week that its project to launch the first effective Alzheimer’s treatment is on the right track—though it still faces hugely long odds.
New IU public health schools reach milestone
Indiana University says an accrediting agency has approved its request to begin the accreditation process for the Schools of Public Health proposed for its Bloomington and Indianapolis campuses.
WellPoint using deals to prep for new era in insurance
The buying spree is back on at WellPoint Inc., with a twist. A decade ago, the insurer consolidated Blue Cross and Blue Shield plans that catered to employers. Today, it is making deals to grow the non-employer part of its business.
WellPoint agrees to pay for 3 children to get gene test
WellPoint Inc. said it will pay for DNA testing for three children to see if they have an inherited heart disease their father suffers from that often strikes without warning, reversing an earlier decision to deny coverage.
Potential Lilly antipsychotic falls short in study
Eli Lilly and Co. said a potential treatment for acute schizophrenia failed in a late-stage study that compared patients taking the drug to those taking a placebo.
Competing Alzheimer’s treatments facing long odds
Johnson & Johnson, Pfizer Inc. and Elan Corp are racing Indianapolis-based Eli Lilly and Co. to market the first broadly available drug designed to target a cause of Alzheimer’s, rather than just its symptoms. Analysts say the potential drugs are long shots.
Zoeller goes after closed Allcare Dental chain
A chain of dental offices that abruptly closed multiple Indiana locations in December 2010 left patients without care, refunds or records, according to a complaint filed by the Office of the Indiana Attorney General.
Local providers join Medicare ACO program
Indiana University Health, as well as a partnership of Franciscan Alliance and American Health Network, have formed accountable care organizations that won the blessing of the federal Medicare Shared Savings program.
Bioanalytical taps accountant for turnaround
With spending running well ahead of revenue, West Lafayette-based Bioanalytical Systems Inc. ousts its CEO in favor of its CFO.
WellPoint shares jump after $4.9B deal for Amerigroup
Investors and analysts like the fact that WellPoint is playing more aggressively in government-sponsored health plans, such as Medicaid and Medicare, which are projected to be the key sectors for growth for the next several years.
WellPoint buying managed care firm for $4.9B
The Indianapolis health insurer is buying Virginia-based Amerigroup Corp. to expand in managed care for poor and elderly patients in the Medicare and Medicaid programs.
Lilly gets 6-month Cymbalta marketing extension
Eli Lilly and Co. said Friday that it has received an extra six months of marketing exclusivity on the antidepressant Cymbalta, its biggest selling drug. The extension could mean more than a billion dollars in sales for the Indianapolis drug maker.
Lilly cancer treatment fails trial in stomach cancer
Erbitux, a cancer treatment made by Indianapolis-based Eli Lilly and Co.'s Imclone unit, failed to help patients with advanced stomach tumors in a late-stage clinical trial.
MILLER: Morale, productivity affected by benefits frustration
Have employees reached the tipping point where rising health care costs have forced them to think seriously about jumping ship?
TOLLIVER: Evolving market dynamics impact medical real estate
As medical innovation continues to flourish in our city … you can expect to see a direct impact on the where and how you and your loved ones receive comprehensive medical services.